Nelson L. Levy
Amministratore Delegato presso CoreTechs Corp.
Profilo
Nelson L.
Levy is the founder of ChemBridge Corp.
(founded in 1993) and holds the title of Director.
He is currently the Chairman & Chief Executive Officer at CoreTechs Corp.
since 1985, Director at zuChem, Inc., and Director at Bryologyx, Inc. since 2021.
Dr. Levy previously served as Director at AmpliPhi Biosciences Corp.
from 1999 to 2010 and as Vice President-Pharmaceutical Research at Abbott Laboratories from 1981 to 1984.
He has a doctorate degree from Duke University and Vagelos College of Physicians & Surgeons, and an undergraduate degree from Yale University.
Posizioni attive di Nelson L. Levy
| Società | Posizione | Inizio |
|---|---|---|
zuChem, Inc.
 zuChem, Inc. Wholesale DistributorsDistribution Services zuChem, Inc. manufactures and supplies glycochemicals for the pharmaceutical, food and related industries. Its products include natural polyols, rare sugars and carbohydrates. Its glycochemicals are key components of many drugs and drug candidates as well as many specialty food ingredients. The company was founded by David C. Demirjian in 2001 and is headquartered in Chicago, IL. | Direttore/Membro del Consiglio | - |
| CoreTechs Corp. | Amministratore Delegato | 01/01/1985 |
Bryologyx, Inc.
 Bryologyx, Inc. Pharmaceuticals: MajorHealth Technology Bryologyx, Inc. operates as a biopharmaceutical company focused on treating cancer immunotherapies. The company was founded by Thomas M. Loarie, John H. Abeles, Paul A. Wender and Sam Kongsamut and is headquartered in Danville, CA. | Direttore/Membro del Consiglio | 21/12/2021 |
ChemBridge Corp.
 ChemBridge Corp. BiotechnologyHealth Technology ChemBridge Corp. is a private company that engages in the research, development, and production of chemical products. The company is based in San Diego, CA. The company was founded by Nelson L. Levy. | Fondatore | 01/01/1993 |
Precedenti posizioni note di Nelson L. Levy
| Società | Posizione | Fine |
|---|---|---|
AmpliPhi Biosciences Corp.
 AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | 13/04/2010 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01/01/1984 |
Formazione di Nelson L. Levy
| Yale University | Undergraduate Degree |
| Duke University | Doctorate Degree |
| Vagelos College of Physicians & Surgeons | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| Aziende private | 5 |
|---|---|
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Health Technology |
zuChem, Inc.
zuChem, Inc. Wholesale DistributorsDistribution Services zuChem, Inc. manufactures and supplies glycochemicals for the pharmaceutical, food and related industries. Its products include natural polyols, rare sugars and carbohydrates. Its glycochemicals are key components of many drugs and drug candidates as well as many specialty food ingredients. The company was founded by David C. Demirjian in 2001 and is headquartered in Chicago, IL. | Distribution Services |
| CoreTechs Corp. | |
Bryologyx, Inc.
Bryologyx, Inc. Pharmaceuticals: MajorHealth Technology Bryologyx, Inc. operates as a biopharmaceutical company focused on treating cancer immunotherapies. The company was founded by Thomas M. Loarie, John H. Abeles, Paul A. Wender and Sam Kongsamut and is headquartered in Danville, CA. | Health Technology |
ChemBridge Corp.
ChemBridge Corp. BiotechnologyHealth Technology ChemBridge Corp. is a private company that engages in the research, development, and production of chemical products. The company is based in San Diego, CA. The company was founded by Nelson L. Levy. | Health Technology |
- Borsa valori
- Insiders
- Nelson L. Levy
